Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.
about
μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacologyIn vivo characterization of the opioid antagonist nalmefene in miceAnalgesic tone conferred by constitutively active mu opioid receptors in mice lacking β-arrestin 2Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.Ligand interaction, binding site and G protein activation of the mu opioid receptorDifferential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclaseOxycodone combined with opioid receptor antagonists: efficacy and safety.The discovery and development of the N-substituted trans-3,4-dimethyl-4-(3'-hydroxyphenyl)piperidine class of pure opioid receptor antagonists.Endogenous analgesia, dependence, and latent pain sensitizationConstitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.Shadows across mu-Star? Constitutively active mu-opioid receptors revisited.The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.GPCR theme editorial.Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
P2860
Q26991859-0CB3D061-0DD2-4F7B-9D3D-2728FFEDE8FBQ33767106-821869AB-B438-4D2E-8AD9-CFB24103E08AQ34957285-27BDE115-3B2A-4438-9F13-865BD5BB9A06Q36591603-5E197B72-8159-481A-A93B-5BAE014B3421Q36717977-C9127527-45C5-4253-8428-431FE0CEF131Q37372214-16244D65-262C-4850-B70D-B554E29235EAQ38093671-ED8B990F-E188-4B26-A677-8E194B499DD2Q38225032-3AC7B599-79E0-4FA8-B89A-69B6CA52E46AQ38250226-16244C66-88CB-4C2F-97EF-EB421460E7F6Q39359627-96D72EDD-2D78-41CE-80A5-93A1C415A999Q39860832-EFCB3098-3412-4E17-9B0C-FDF21AC4B902Q42090559-EF7EF03C-68F5-4AE9-846F-BD8F295952B2Q42951309-EEEA70BD-E153-4CE9-9F2B-FF82D40A304EQ43196990-E923EAEF-CE9A-4D44-91E1-2EB89A0CDF22Q56889524-A455CDF9-0493-4822-B995-FA38DB883CE6
P2860
Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@en
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@nl
type
label
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@en
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@nl
prefLabel
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@en
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@nl
P2093
P2860
P1476
Neutral antagonist activity of ...... pressing a mu-opioid receptor.
@en
P2093
F A Bradbury
F I Carroll
J R Traynor
P2860
P304
P356
10.1111/J.1476-5381.2008.00035.X
P407
P577
2009-02-13T00:00:00Z